Media Database
>
Andrew Silver

Andrew Silver

Reporter at Reuters News

Contact this person
Email address
a*****@*******.comGet email address
Influence score
21
Phone
(XXX) XXX-XXXX Get mobile number
Location
United Kingdom
Languages
  • English
Covering topics
  • Business
  • Health & Medicine
  • Technology

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

reuters.com

Chinese industry to seek probe into EU dairy imports, Global Times reports

Chinese companies plan to ask authorities to open an "anti-subsidy" investigation into imports of some dairy products from the European Union, the state-backed Global Times newspaper reported on Saturday, citing an unidentified "business insider".
reuters.com

Second Chinese drugmaker seeks approval for Ozempic generic

A second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk's blockbuster diabetes drug Ozempic in China.
reuters.com

India's Biocon seeks partner to test generic Wegovy, Ozempic in China

Jun 20, 2024 ... India's Biocon is searching for a partner in China to test generic versions of Novo Nordisk's hot-selling diabetes drug Ozempic and weight ...
reuters.com

Novo Nordisk's Wegovy weight-loss drug approved in China

Jun 25, 2024 ... Novo Nordisk's hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and ...
reuters.com

China approves CSPC Pharma mRNA cancer therapy for clinical trials

Jun 25, 2024 ... A cancer cell therapy from CSPC Pharmaceutical Group that uses synthetic messenger RNA (mRNA) technology has received regulatory clearance ...
reuters.com

China approves CSPC Pharma's RSV vaccine for clinical trials

9 hours ago ... China's National Medical Products Administration has given regulatory clearance for CSPC Pharmaceutical Group's respiratory syncytial virus ...
reuters.com

Eli Lilly's weight loss drug tirzepatide gets approval in China

10 hours ago ... Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, ...
reuters.com

Drug giants eye China for deals despite growing Sino-US tensions

2 days ago ... Bristol Myers Squibb, Sanofi looking at China M&A -employees · AstraZeneca, Novartis have done China deals this year · Political risks are a ...
reuters.com

How Asian pharma suppliers cash in on Ozempic copies

Semaglutide, a patented substance that helps control blood sugar levels and appetite, is the key ingredient in Novo Nordisk's blockbuster drugs.
reuters.com

EU does not want trade war with Beijing, says bloc's ambassador to ...

The EU does not want a trade war with Beijing but five years of talks have yielded no real progress, the bloc's ambassador to China said on Saturday, adding that concern was growing over Chinese market access for European medical devices.
reuters.com

AstraZeneca's Enhertu breast cancer drug added to China's state ins...

AstraZeneca's blockbuster breast cancer drug Enhertu will be added to China's state-run health insurance scheme from Jan. 1, according to an update from the National Healthcare Security Administration.